Home/Filings/4/0000950170-25-089976
4//SEC Filing

Gaslightwala Abizer 4

Accession 0000950170-25-089976

CIK 0001541157other

Filed

Jun 24, 8:00 PM ET

Accepted

Jun 25, 4:30 PM ET

Size

6.8 KB

Accession

0000950170-25-089976

Insider Transaction Report

Form 4
Period: 2025-06-23
Transactions
  • Purchase

    American Depositary Shares representing Ordinary Shares

    2025-06-23$1.15/sh+943$1,084272,371 total
  • Purchase

    American Depositary Shares representing Ordinary Shares

    2025-06-24$1.16/sh+5,203$6,035277,574 total
Footnotes (2)
  • [F1]Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.15 to $1.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in this footnote.

Documents

1 file

Issuer

Akari Therapeutics Plc

CIK 0001541157

Entity typeother

Related Parties

1
  • filerCIK 0002049375

Filing Metadata

Form type
4
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 4:30 PM ET
Size
6.8 KB